Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Etanercept
Enbrel
Routinely available
NICE (TA455 (SMC 781/12))
30/05/2012
Indication
For the treatment of chronic severe plaque psoriasis in children and adolescents from the age of 6 years who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.
Therapeutic Area
Skin
Status Description
Routinely available in line with national guidance
Formulation
10mg and 25mg powder and sterile water for solution for injection for paediatric use
Comments
May 2012 - Included on the Additional List for the indication in question. Specialist Use only. July 2017 - NICE MTA advice: SMC advice 781/12 is superseded by NICE TA455. June 2019 (as per LJF) - Routinely available in line with national guidance. Included in the Additional List, for Specialist Use only.
Link to Advice
Advice Published
12/07/2017